The diverticulitis market comprises treatment medications such as antibiotics, anti-inflammatory drugs, pain medications and surgery related products such as stents or drainage tubes that help in managing diverticulitis disease. Diverticulitis refers to the inflammation or infection of small pouches called diverticula that bulge out from the lower part of the colon. Diverticulitis often causes symptoms like abdominal pain, nausea, fever and tenderness.
The global diverticulitis diagnostic market is estimated to be valued at US$ 1.2 Billion in 2030 and is expected to exhibit a CAGR of 5.5% over the forecast period 2025-2030.
Key Takeaways
Key players operating in the diverticulitis market are Pfizer, Merck, Johnson & Johnson, Abbott Laboratories, Bayer, GlaxoSmithKline and Novartis.
The key opportunities in the diverticulitis market include growing geriatric population prone to diverticulitis, increasing awareness about the disease, availability of various treatment options and medications and development of new drugs with minimal side effects.
Globally there has been rising prevalence of diverticulitis owing to factors such as sedentary lifestyle, unhealthy diet low in fiber and growing consumption of processed packaged foods. This is expected to drive the global expansion of diverticulitis market in coming years especially in developing regions.
Market Drivers
The rising prevalence of diverticulitis owing to changing dietary habits and lack of physical exercise is a major market driver. According to National Institute of Diabetes and Digestive and Kidney Diseases, around 10-25% of Americans over the age of 60 suffer from diverticular disease. This increases the demand for diagnosis, treatment and management of disease thereby fueling market growth.
PEST Analysis
Political: Government regulations regarding medical device approvals, import duties, and healthcare reforms could impact the diverticulitis market.
Economic: Fluctuations in the global economy that affect healthcare spending by governments and consumers may influence the diverticulitis drug and device market.
Social: Rising awareness among patients about diverticulitis diagnosis and treatment options is driving the market growth. Population aging trends also contribute to the market expansion.
Technological: Developments in minimally invasive surgical techniques and drug delivery systems lower treatment costs and improve patient outcomes, supporting the diverticulitis market. Advancements in biologics and targeted medicines create new opportunities.
Geographical Regions
The diverticulitis market is currently concentrated in developed regions with advanced healthcare infrastructures and systems. North America holds the largest share, driven by a growing elderly patient base and high medical spending in the U.S. and Canada. Western Europe is the second largest regional market due to the presence of major players and favorable reimbursement scenario. Access to state-of-the-art therapies across countries such as Germany and the UK augment the European diverticulitis drug and device demand.
Fastest Growing Regional Market
The Asia Pacific diverticulitis market is predicted to experience the fastest gains during the forecast period. Factors such as rising healthcare investments, growing cases linked to changing dietary habits and lifestyles, increasing willingness to pay for premium treatments, and expanding medical tourism are fueling the regional opportunities. Emerging nations like India, China, and South Korea represent high-potential markets, facilitated by their huge populations and improving diagnostic capabilities.
What Are The Key Data Covered In This Diverticulitis Diagnostic Market Report?
:- Market CAGR throughout the predicted period
:- Comprehensive information on the aspects that will drive the Diverticulitis Diagnostic ‘s growth between 2024 and 2031.
:- Accurate calculation of the size of the Diverticulitis Diagnostic and its contribution to the market, with emphasis on the parent market
:- Realistic forecasts of future trends and changes in consumer behaviour
:- Diverticulitis Diagnostic Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa
:- A complete examination of the market’s competitive landscape, as well as extensive information on vendors
:- Detailed examination of the factors that will impede the expansion of Diverticulitis Diagnostic vendors
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
About Author – Ravina Pandya
Ravina Pandya,a content writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemicals and materials, etc. With an MBA in E-commerce, she has expertise in SEO-optimized content that resonates with industry professionals. LinkedIn Profile